Avanos Medical Inc (NYSE:AVNS) Receives $36.25 Consensus PT from Analysts

Avanos Medical Inc (NYSE:AVNS) has been given an average recommendation of “Hold” by the nine brokerages that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $35.00.

AVNS has been the topic of a number of analyst reports. Stephens reduced their price target on Avanos Medical from $40.00 to $30.00 and set an “overweight” rating on the stock in a research report on Monday. TheStreet lowered Avanos Medical from a “c-” rating to a “d+” rating in a research report on Monday, February 10th. Barclays reaffirmed a “sell” rating and issued a $32.00 price target on shares of Avanos Medical in a research report on Thursday, February 27th. Morgan Stanley reduced their price target on Avanos Medical from $36.00 to $32.00 and set an “underweight” rating on the stock in a research report on Tuesday, December 17th. Finally, ValuEngine raised Avanos Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, February 25th.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Retirement Systems of Alabama raised its position in shares of Avanos Medical by 0.6% during the 4th quarter. Retirement Systems of Alabama now owns 62,411 shares of the company’s stock worth $2,103,000 after acquiring an additional 391 shares in the last quarter. Mason Street Advisors LLC raised its position in shares of Avanos Medical by 1.9% during the 4th quarter. Mason Street Advisors LLC now owns 25,493 shares of the company’s stock worth $859,000 after acquiring an additional 473 shares in the last quarter. Amalgamated Bank raised its position in shares of Avanos Medical by 9.3% during the 4th quarter. Amalgamated Bank now owns 7,935 shares of the company’s stock worth $267,000 after acquiring an additional 673 shares in the last quarter. American International Group Inc. raised its position in shares of Avanos Medical by 0.6% during the 4th quarter. American International Group Inc. now owns 121,370 shares of the company’s stock worth $4,090,000 after acquiring an additional 748 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Avanos Medical by 1.2% during the 3rd quarter. California State Teachers Retirement System now owns 73,715 shares of the company’s stock worth $2,761,000 after acquiring an additional 881 shares in the last quarter. 96.71% of the stock is currently owned by institutional investors and hedge funds.

AVNS stock traded up $2.64 during mid-day trading on Monday, reaching $25.58. The company had a trading volume of 450,600 shares, compared to its average volume of 431,515. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.85 and a current ratio of 2.53. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of -26.37 and a beta of 1.16. The firm has a fifty day simple moving average of $29.07 and a 200 day simple moving average of $33.70. Avanos Medical has a fifty-two week low of $19.46 and a fifty-two week high of $48.07.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.02. The company had revenue of $189.80 million for the quarter, compared to analyst estimates of $178.58 million. Avanos Medical had a positive return on equity of 3.99% and a negative net margin of 6.58%. Avanos Medical’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.30 EPS. As a group, analysts predict that Avanos Medical will post 1.1 earnings per share for the current year.

About Avanos Medical

Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.

Featured Story: Diversification For Individual Investors

Analyst Recommendations for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.